Drugs / FK50
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00048412 Background | Jun 2000 → Nov 2004 | leukemia, lymphoproliferative syndrome, myelodysplastic syndrome, plasma cell myeloma | Baylor College of Medicine | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FK50 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00048412 ↗ |